ANIK - Anika Therapeutics, Inc.

14.68
0.140   0.954%

Share volume: 50,102
Last Updated: 05-12-2026
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: -0.03%

PREVIOUS CLOSE
CHG
CHG%
$14.54
0.14
0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
36%
Profitability 35%
Dept financing 28%
Liquidity 75%
Performance 30%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-0.61%
1 Month
-1.41%
3 Months
43.78%
6 Months
45.35%
1 Year
18.29%
2 Year
-42.57%
Key data
Stock price
$14.68
P/E Ratio 
0.00
DAY RANGE
$14.38 - $14.75
EPS 
-$0.79
52 WEEK RANGE
$7.87 - $16.24
52 WEEK CHANGE
$29.68
MARKET CAP 
194.311 M
YIELD 
N/A
SHARES OUTSTANDING 
13.306 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-07-2025
BETA 
0.81
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$98,040
AVERAGE 30 VOLUME 
$128,186
Company detail
CEO: Cheryl R. Blanchard
Region: US
Website: anikatherapeutics.com
Employees: 300
IPO year: 1993
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

Anika Therapeutics, Inc. creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. The company develops, manufactures, and commercializes products based on hyaluronic acid (HA) technology platform.

Recent news